Q: Hi team
I am looking to start a position in global value ETF fund; I am looking at the above
VVL; I already have some exposure in International through the Mawer International funds
could you recommend one more ETF similar to VVL ?
I am considering an investment in BioNTech. I'm just wondering about the possible upside and downside if the company is successful or unsuccessful in getting approval for their vaccine candidate?
Q: Hi, Any comments or read into the 4 large block trades/cross with a total of 759,700 shares by Acumen Capital, Thursday ? On Wednesday also, there was a large trade of 34,200 shares. For a thin trader like Sylogist, it's a bit out of norm. Someone, building a large position or NCIB buybacks by the company ? Thanks
Q: Hi
I have been renovating an old cottage on the east coast, it seems that the supply chain has “broken” when trying to get lumber supplies to the extent that builders are saying forget about new builds.
Is there a buying opportunity here for lumber companies and if so what companies would you suggest.
Thanks
Melissa
Q: hello
What is your view of Fax Capital ? I understand this is like buying a small cap mutual fund of sorts. So it all comes down to management prior success. Do they have a track record of active ownership either at Fax or previously ?
thanks
My question is on Intermap Technologies Corporation. The stock has had a big run lately and mainly due to a debt restructuring deal. Its ~34M of debt (which was crippling the company before) will be settled in this private placement for 1M dollars. Moreover, it's subscription business is growing which should provide a solid foundation for the company. With a few more contracts and the debt settled, this company should be EPS going forward. If so, the companies $190M NOL carry-forwards should convert to deferred tax asset (which would be larger than the market cap). Not to mention, its tangible and off-balance sheet assets...
What are you thoughts on this company going forward? Am I missing something in my analysis.. this stock still seems cheap (assuming the debt conversion takes place). I look forwars to your reply.
Q: Hi Peter, Ryan, and Team,
I know you continue to like Loblaws, which we own. We also own Metro, which has a much better one-year chart. Is there a compelling reason to continue to hold L? Why is it such a laggard? It appears to me that the Shoppers Drug Mart acquisition didn't really yield the results that one may have expected. Am I wrong about this? Your insight is invaluable.
Q: Hello,
recently I was listening to an interview of a portfolio manager of Artemis Capital. He was discussing portfolio construction and allocations to different types of investment classes.
His firm did research over an extended period of time and they devised an allocation model which performed the best over the time frame. The main point of the interview was diversification which would be in line with what 5i keeps saying time and time again when reading replies to member questions.
Having said all that, there is one point they made which I did not follow to well and would like your view on. They indicated that they would allocate a portion of a portfolio to volatility. Anyway, I did not understand and would like to know what they meant by this. They were talking about options so is it basically using puts and calls?
If you can expand on what would constitute investing in volatility and perhaps give a few examples i would appreciate it to help my understanding of this concept.
Thanks,
Dan
Q: GUY is suppose to be taken over at $1.85 cash and close end of this month, but its trading at 1.78 currently, why the discount? Is there any major risk of this deal falling apart? Any major regulatory approval missing? Thanks
Q: ACQ has ticked up but I am still at a 50% loss (registered act). In the interest of getting rid of laggards and an attempt to high grade into quality names currently at discounts...would you cut your losses on this one or hold for recovery
Q: Poor old TH is doing nothing. There drugs seem to be recognized as good. What is wrong ? Do they lack direction. Do they need something new. Are they working on C19 vaccine Should I start accumulating or leave it alone. RAK